• 1
    Ong KL, Cheung BMY, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007;49:6975.
  • 2
    Ostchega Y, Yoon SS, Hughes J, et al. Hypertension awareness, treatment, and control-continued disparities in adults: United States, 2005–2006. NCHS Data Brief. 2008;3:18.
  • 3
    Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290:199206.
  • 4
    Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47:345351.
  • 5
    Andrade SE, Gurwitz JH, Field TS, et al. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care. 2004;10:481486.
  • 6
    Fotherby MD, Critchley D, Potter JF. Effect of hospitalization on conventional and 24-hour blood pressure. Age Ageing. 1995;24:2529.
  • 7
    Nielsen PE, Hilden T. Intra-arterial blood pressure measured during 24-hours in evaluation of hypertensive subjects. Acta Med Scand Suppl. 1979;625:9296.
  • 8
    Young MA, Rowlands DB, Stallard TJ, et al. Effect of environment on blood pressure: home versus hospital. Br Med J (Clin Res Ed). 1983;286:12351236.
  • 9
    Conen D, Martina B, Perruchoud AP, et al. High prevalence of newly detected hypertension in hospitalized patients: the value of in-hospital 24-h blood pressure measurement. J Hypertens. 2006;24:301306.
  • 10
    Merrill C, Elixhauser A. Hospitalization in the United States, 2002. Rockville, MD: Agency for Healthcare Research and Quality; 2005. HCUP Fact Book No. 6. AHRQ Publication No. 05-0056. ISBN 1-58763-217-9.
  • 11
    Mangano DT. Perioperative medicine: NHLBI working group deliberations and recommendations. J Cardiothorac Vasc Anesth. 2004;18:16.
  • 12
    Jankowski P, Kawecka-Jaszcz K, Bilo G, et al. Determinants of poor hypertension management in patients with ischaemic heart disease. Blood Press. 2005;14:284292.
  • 13
    Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373383.
  • 14
    Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613619.
  • 15
    Duru OK, Vargas RB, Kermah D, et al. Health insurance status and hypertension monitoring and control in the United States. [see comment]. Am J Hypertens. 2007;20:348353.
  • 16
    Tu K, Campbell NR, Chen Z, et al. Thiazide diuretics for hypertension: prescribing practices and predictors of use in 194,761 elderly patients with hypertension. Am J Geriatr Pharmacother. 2006;4:161167.
  • 17
    Morgan S, Bassett KL, Wright JM, et al. First-line first? Trends in thiazide prescribing for hypertensive seniors PLoS Med/Public Library of Science. 2005;2:e80.
  • 18
    Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care. 2002;40:675685.
  • 19
    Humphries KH, Rankin JM, Carere RG, et al. Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review? J Clin Epidemiol. 2000;53:343349.